A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

NCT06401603 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Chronic Myeloid Leukemia
Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Interventions

DRUG: Decitabine
DRUG: Listaftoclax
DRUG: Olverembatinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]